Clinical Trials Browser

Withdrawn × semaglutide × 30 days × Clear all

NCT06222437 2026-03-23

Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy

Phase 1 Withdrawn

Polycystic Ovary Syndrome